Get the Stockscreener App
2.67
2.30%
0.06
Pre-market:
2.61
-0.06
-2.25%
Cronos Group Inc stock is traded at $2.67, with a volume of 2.36M.
It is up +2.30% in the last 24 hours and down -3.26% over the past month.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
See More
Previous Close:
$2.61
Open:
$2.62
24h Volume:
2.36M
Relative Volume:
1.60
Market Cap:
$997.68M
Revenue:
$146.59M
Net Income/Loss:
$-2.93M
P/E Ratio:
-109.43
EPS:
-0.0244
Net Cash Flow:
$-190.40K
1W Performance:
-2.20%
1M Performance:
-3.26%
6M Performance:
+16.09%
1Y Performance:
+27.75%
1-Day Range:
$2.61
$2.68
1-Week Range:
$2.56
$2.7655
52-Week Range:
$1.84
$3.43
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
(416) 504-0004
Address
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
2.67 | 978.99M | 146.59M | -2.93M | -190.40K | -0.0244 |
TAK
Takeda Pharmaceutical Co Adr
|
16.68 | 52.36B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.28 | 40.62B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.32 | 39.63B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.71 | 32.58B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
563.93 | 24.07B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
| Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
| Nov-18-21 | Resumed | BofA Securities | Underperform |
| Apr-28-21 | Resumed | BofA Securities | Underperform |
| Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
| Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
| Mar-03-20 | Downgrade | Stifel | Buy → Hold |
| Oct-18-19 | Upgrade | Stifel | Hold → Buy |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Aug-13-19 | Initiated | Piper Jaffray | Overweight |
| Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
| Apr-17-19 | Initiated | BofA/Merrill | Underperform |
| Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-25-19 | Initiated | Jefferies | Underperform |
| Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
Does Stronger Q1 Profitability And Spinach Vape Gains Change The Bull Case For Cronos Group (TSX:CRON)? - simplywall.st
Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch
Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN
Cannabis Stocks Draw Attention As Rescheduling Debate Gains Momentum - Kalkine Media
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Cronos Expands Spinach STIX Pre Rolls And Chases Canadian Market Share - Yahoo Finance
Cronos Group stock (CA22717L1013): cannabis player shifts focus as Q1 loss widens - AD HOC NEWS
Cronos targets Canadelaar close in summer 2026 while renewing $50M buyback - MSN
Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch
Is Cronos Group stock a buy? - Cantech Letter
CRON.CA Stock Price, Quote & Chart | CRONOS GROUP INC (TSX:CRON) - ChartMill
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales - Seeking Alpha
Cronos Group (CRON) officer exercises 10,597 RSUs, with 5,199 shares for tax - Stock Titan
Cronos Group (CRON) officer receives 10,367 shares as RSUs vest - Stock Titan
Cronos Group (CRON) officer exercises RSUs and withholds shares to cover taxes - Stock Titan
Cronos Group (CRON) officer settles RSUs and tax withholding shares - Stock Titan
CRON Stock Price, Quote & Chart | CRONOS GROUP INC (NASDAQ:CRON) - ChartMill
Cronos Group Inc. stock falls Wednesday, underperforms market - MarketWatch
Short-Seller Left Didn’t Make ‘Sense,’ Cronos CEO Testifies - Bloomberg.com
Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade) (NASDAQ:CRON) - Seeking Alpha
Cronos Group stock (CA22717L1013): Q1 revenue hits record $45.2M amid rescheduling boost - AD HOC NEWS
Cronos Group (CRON) Q1 earnings meet estimates - MSN
Short-Seller Left ‘Didn’t Make Much Sense,’ Cronos CEO Testifies - Bloomberg.com
Cronos Group (CRON) executive converts 3,118 RSUs into common shares, holding 211,555 shares - Stock Titan
Cronos Group (NASDAQ: CRON) officer converts RSUs into 20,470 common shares - Stock Titan
Cronos Group (CRON) officer exercises RSUs, uses 4,774 shares for taxes - Stock Titan
TD Cowen Maintains Cronos Group(CRON.US) With Buy Rating, Raises Target Price to $4.02 - Moomoo
Cronos Group Reports 2026 First Quarter Results - Sahm
Cronos Group Announces New Share Buyback After Strong Quarter - The Globe and Mail
Cronos Group Inc (CRON) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus
Cronos Quarterly Earnings Buoyed by Rise in Sales Volumes - Moomoo
CEO testifies that short-seller Andrew Left triggered investor panic and threw him into damage control - Business Insider
Cronos Group Q1 Net Income, Revenue Rise - Moomoo
Cronos Group Inc. (CRON) Reports Record Revenue and Market Growt - GuruFocus
Earnings call transcript: Cronos Group Q1 2026 earnings beat forecasts By Investing.com - Investing.com Australia
Cronos Group (CRON) Q1 2026: EPS $0.04 Beats ($0.01 est), Revenu - GuruFocus
Cronos Group Inc. stock rises Monday, outperforms market - MarketWatch
Cronos Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CRON Delivers Strong Q1 Revenue Growth - GuruFocus
Cronos Group Q1 2026 Financial Results: Net Income Surges to $15.7M with Strong Revenue Growth - Minichart
Promising Cannabis Stocks To Follow TodayMay 11th - MarketBeat
Cronos Group (NASDAQ:CRON) Releases Earnings Results, Meets Estimates - MarketBeat
Cronos Group Q1 2026 Earnings Call Transcript - MarketBeat
Cronos Reports Record Net Revenue and Gross Profit in Q1 2026, Driven By Record International Sales - StratCann
Cronos Group Inc. (CRON) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
Cronos Group Q1 earnings call highlights - MSN
Cronos Group (CRON) Reports Strong Earnings and Strategic Expans - GuruFocus
Cronos Group Inc. - Baystreet.ca
Cronos Group Achieves Record Q1 2026 Results With Market-Leading Spinach Brand and Strong Financial Performance - Minichart
Cronos Group Q1 Earnings Call Highlights - MarketBeat
Cronos Group (CRON) Reports Strong Q1 Earnings, Beats Expectatio - GuruFocus
Cronos Group Inc Stock (CRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.30%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):